Group Urges Advisory Opinions For Clinical-Decision Support Products

The Clinical Decision Support Coalition is urging US FDA to use an advisory-opinion model guidance format to help clarify its thinking on clinical-decision support products that does not lock the agency into an approach that can't keep up with a rapidly changing sector.

The Clinical Decision Support (CDS) Coalition says US FDA has accepted its request to meet and discuss a citizen petition filed by the group recently urging the agency to develop much-needed guidance for the sector. However, the agency has not set a date for the meeting yet, according to Bradley Thompson, an attorney with the law firm Epstein Beck Green who represents the CDS Coalition.

In August, the coalition sent FDA a citizen petition asking it to consider using an advisory-opinion model to develop guidances for the industry. The group says it tried to think...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation